BIOA (Bioage Labs) EV-to-EBITDA : -26.09 (As of Oct. 08, 2024)

Bioage Labs EV-to-EBITDA Chart

Competitive Comparison of Bioage Labs's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bioage Labs's EV-to-EBITDA falls into.

Bioage Labs EV-to-EBITDA Calculation

Bioage Labs's EV-to-EBITDA for today is calculated as:

Bioage Labs's current Enterprise Value is $647.77 Mil.
Bioage Labs's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs  (NAS:BIOA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bioage Labs's PE Ratio (TTM) for today is calculated as:

Bioage Labs's share price for today is $22.30.
Bioage Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.777.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Bioage Labs EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bioage Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description